Visalytics
Visalytics
dismissed EB-2 (NIW)

Pharmaceutical Industrial Production Manager

Pharmaceutical Industry · 2024-07-10

Decision Date
2024-07-10
This case is from a USCIS Administrative Appeals Office (AAO) appeal decision. Appeal cases represent a subset of petitions and may not reflect typical outcomes.

Proposed Endeavor

The Petitioner proposes to work as a pharmaceutical industrial production manager, planning and coordinating activities for the manufacture of pharmaceutical products. He aims to implement risk mitigation strategies to ensure the supply of safe medicines and anticipate drug shortages.

Framework Evaluation

0 of 3 criteria met
1 Substantial Merit and National Importance Not Met

The endeavor has substantial merit but the Petitioner failed to demonstrate its national importance or broader implications beyond his immediate employer.

Why This Petition Was Denied

The appeal was dismissed because the Petitioner failed to establish the national importance of his endeavor under the first Dhanasar prong. While the field is important, the record did not show that his specific work for one company would have broader industry implications, significant U.S. job creation, or substantial economic effects.

Evidence

Evidence Types
Reference Letters Dependent
Government Alignment

Similar Cases

Others

Pharmaceuticals

USCIS EB-2 (NIW) dismissed
2024-10-21
The Beneficiary proposes to streamline and ensure the quality of pharmaceutical research, development, and regulatory approval processes through the development, enhancement, and maintenance of cloud, DevOps, and database systems. This involves enhancing clinical data management systems to automate drug development, protect sensitive patient data, and integrate cloud and AI automation technologies to optimize the process.

Business Manager

Pharmaceuticals · Brazil

USCIS EB-2 (NIW) rfe dismissed
2024-05-29
The petitioner proposes to work as a business manager overseeing operations, implementing management guidelines, and creating sales strategies. He intends to focus on the pharmaceutical distribution niche, applying technical skills to organize business structures and automate processes to increase efficiency and profits.

Others

Pharmaceuticals · India

USCIS EB-2 (NIW) dismissed
2024-11-18
The Beneficiary proposes to continue working as an Associate Director, Master Data Management (MDM) Implementation Lead for a pharmaceutical company. His endeavor involves developing, implementing, and managing digital platforms using AI and machine learning to optimize laboratory workflows, integrate clinical trial data, ensure data security, improve access to high-quality information, and accelerate drug research, development, and regulatory approval processes.

General Manager

Pharmaceuticals

USCIS EB-2 (NIW) rfe dismissed
Virginia 2025-04-07
The petitioner proposes to operate a chain of pharmacies providing low and average cost prescription medicines to elderly and economically disadvantaged communities. The plan involves establishing a headquarters in Virginia and expanding to Maryland, focusing on affordable quality medicine.

Frequently Asked Questions

A dismissed EB-2 NIW petition means USCIS found the evidence insufficient to meet the eligibility criteria. Common reasons include weak documentation, failure to meet the required number of criteria, or insufficient evidence of the claimed qualifications. Petitioners can refile with stronger evidence or explore alternative visa categories.

Browse More Cases

More dismissed cases More Pharmaceuticals cases

Case data sourced from publicly available petition decisions and case studies. Decision date: 2024-07-10.

Browse all cases

At a Glance

Outcome dismissed
Criteria Met 0 / 3
Evidence Types 2

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,895
Success Rate 54.2%
Sustained 2,112
Dismissed 1,687

Related Pages

EB-2 (NIW) Overview All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist